> Home Page > Faculty > Dr. David Juurlink BioSketch

Dr. David Juurlink BioSketch

Untitled Document
davidJuurlink


David N. Juurlink BPhm, MD, PhD, FRCPC


Primary Appointment
Associate Professor of Medicine, Pediatrics, and Health Policy, Management, and Evaluation, Attending Physician, Division of General Internal Medicine,
Head, Division of Clinical Pharmacology and Toxicology,
Sunnybrook Health Sciences Centre
Scientist, Institute for Clinical Evaluative Sciences
Medical Toxicologist for Ontario Poison Centre

Contact
Sunnybrook Health Sciences Centre
G Wing 106

2075 Bayview Avenue,
Toronto, Ontario

M4N 3M5

t: (416) 480-6100 x 3039
f: (416) 480-6048


Assistant
Mr. Ashif Kachra
ashif.kachra@ices.on.ca
t: (416) 480-4835


Dr. Juurlink is an internist and Head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto. He is also a Medical Toxicologist at the Ontario Regional Poison Information Centre at the Hospital for Sick Children and a Scientist at the Institute for Clinical Evaluative Sciences.

He received degrees in Pharmacy and Medicine from Dalhousie University in Halifax, Nova Scotia, and completed postgraduate training in Internal Medicine followed by residency in Clinical Pharmacology, a fellowship in Medical Toxicology, and a PhD in Clinical Epidemiology, all at the University of Toronto. He is certified by the American Board of Internal Medicine, the American Board of Clinical Pharmacology, and the American Board of Emergency Medicine (Medical Toxicology.)

He is presently the Sunnybrook site director for the program in Clinical Pharmacology and Vice-Chair of the Royal College Clinical Pharmacology and Toxicology. He is also Chair of the Examination Committee for the American Board of Clinical Pharmacology, and a member of the Board of Trustees of the American Academy of Clinical Toxicology.

In addition to his clinical, teaching, and administrative activities, David maintains an active research program in the field of drug safety, supported by a New Investigator Award from the Canadian Institutes for Health Research. His areas of interest include adverse drug events, the epidemiology of drug-drug interactions, and the epidemiology of suicide and parasuicide.

logo Department of Medicine